SION FY 2023 Earnings — Sionna Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SIONSionna Therapeutics, Inc.

$2B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$50M

Net Income

-$47M

EPS (Diluted)

$-1.07

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$45M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$52M

Total Liabilities

$167M

Stockholders' Equity

-$115M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$50M	-$41M	-21.7%
Net Income	-$47M	-$40M	-17.5%